Sign Up to like & get
recommendations!
1
Published in 2019 at "Biotechnology Progress"
DOI: 10.1002/btpr.2725
Abstract: Recombinant adeno‐associated viral vectors (rAAV) are promising therapies for genetic diseases. Although current platforms for recombinant vector production can generate drug material for pre‐clinical and clinical studies, rAAV biomanufacturing will eventually face commercial supply challenges…
read more here.
Keywords:
vector;
dna replication;
raav;
yield ... See more keywords